TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced July 3, 1981
TCL Archive Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC. November 19, 2004